DEF 14AThe Ballot
Theriva Biologics, Inc. files DEF 14A
Filed Sep 30, 2024 · 1y ago · Accession 0001104659-24-104372
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Theriva Biologics, Inc.
- Ticker
- TOVX
- CIK
- 894158
- Form type
- DEF 14A
- Filing date
- Sep 30, 2024
- Report date
- Oct 31, 2024
- Document
- tm2425198d1_def14a.htm
- Size
- 2.2 MB